Search - tctmd.com

Displaying 121 - 140 of 417

Sort: Relevancy | Date

News Conference News TCT 2020

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Michael O'Riordan

October 14, 2020

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

Presentation TCT 2020

TCT 698: Treatment of Severe Symptomatic Carotid Artery Stenosis in a Medically Complex Patient With High Surgical Risk Utilizing the MOMA Proximal Protection Device

Presenter: Marina Iskandir

October 14, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Conference News TCT 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

L.A. McKeown

October 09, 2019

News Conference News TCT 2019

Pacemaker-Based Approach Tricks the Body Into Lower BP: MODERATO II

Todd Neale

October 09, 2019

News Conference News TCT 2019

Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II

Yael L. Maxwell

October 08, 2019

News Conference News TCT 2019

In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock

Caitlin E. Cox

October 04, 2019

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Todd Neale

October 04, 2019

News Conference News TCT 2019

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Michael O'Riordan

September 30, 2019

News Conference News TCT 2019

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Shelley Wood

September 29, 2019

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Todd Neale

September 29, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Four: Costs and Quality of Life Take Center Stage

Shelley Wood

September 29, 2019

News Opinion Off Script TCT 2019

Off Script: The New Gatekeepers of Procedural Education

Kwan S. Lee

September 28, 2019

Presentation TCT 2019

State of the Art: Latest Insights into the Pathophysiology and Medical and Device-Based Therapies for HFpEF

Presenter: Peter Carson

September 28, 2019

Presentation TCT 2019

After the Champagne for PMA Approval Come Your Obligations: Inspections, Postapproval Studies, Medical Device Reporting, and Recalls

Presenter: Megha Reddy

September 28, 2019

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

News Conference News TCT 2019

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Shelley Wood

September 28, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Shelley Wood

September 28, 2019

News Conference News TCT 2019

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

L.A. McKeown

September 28, 2019

Advertisement

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

TCT 698: Treatment of Severe Symptomatic Carotid Artery Stenosis in a Medically Complex Patient With High Surgical Risk Utilizing the MOMA Proximal Protection Device

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

Pacemaker-Based Approach Tricks the Body Into Lower BP: MODERATO II

Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II

In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

TCT 2019 Day Four: Costs and Quality of Life Take Center Stage

Off Script: The New Gatekeepers of Procedural Education

State of the Art: Latest Insights into the Pathophysiology and Medical and Device-Based Therapies for HFpEF

After the Champagne for PMA Approval Come Your Obligations: Inspections, Postapproval Studies, Medical Device Reporting, and Recalls

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content